New Insights Into Refractory Chronic Cough and Unexplained Chronic Cough: A 6-Year Ambispective Cohort Study

被引:3
|
作者
Zhang, Mengru [1 ,2 ]
Morice, Alyn H. [2 ,4 ]
Si, Fengli [1 ]
Zhang, Li [1 ]
Chen, Qiang [1 ]
Wang, Shengyuan [1 ]
Zhu, Yiqing [1 ]
Xu, Xianghuai [1 ]
Yu, Li [1 ]
Qiu, Zhongmin [1 ,3 ]
机构
[1] Tongji Univ, Tongji Hosp, Sch Med, Dept Pulm & Crit Care Med, Shanghai, Peoples R China
[2] Univ Hull, Castle Hill Hosp, Ctr Clin Sci, Hull York Med Sch, Cottingham, East Yorks, England
[3] Tongji Univ, Tongji Hosp, Sch Med, Dept Pulm & Crit Care Med, 389 Xincun Rd, Shanghai 200065, Peoples R China
[4] Univ Hull, Castle Hill Hosp, Hull York Med Sch, Ctr Clin Sci Resp Med, Castle Rd, Cottingham HU165JQ, E Yorks, England
关键词
Cough; cough hypersensitivity syndrome; population characteristics; treatment outcome; HYPERSENSITIVITY SYNDROME; SENSITIVITY;
D O I
10.4168/aair.2023.15.6.795
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Purpose: Only limited studies have depicted the unique features and management of refractory chronic cough (RCC) and unexplained chronic cough (UCC). These led to the initiation of this study, which reported the demographic characteristics, manifestations, and long-term outcomes on a large series of consecutive RCC/UCC patients, providing a guideline-led real-world clinical experience.Methods: Retrospective baseline information was obtained from Clinical Research Database (January 2016 to May 2021). At least 6 months after the last clinic visit, included subjects were prospectively followed up.Results: Three hundred and sixty-nine RCC and UCC patients (199 females, 53.9%) were analyzed. The median cough duration was 24.0 (12.0-72.0) months. Laryngeal symptoms were reported in 95.9% of the patients. The common triggers for coughing were talking (74.9%), pungent odors (47.3%), eating (45.5%), and cold air (42.8%). RCC was considered in 38.2%, and the remainder of 228 patients had UCC, with an equal sex distribution (P = 0.66). Among the 141 RCCs, 90.8% (128) had refractory reflux cough, which was more responsive to current treatments (P < 0.01). Although most features and test results between RCC and UCC were similar, UCC was more commonly inappropriately treated (P < 0.01). Nineteen (7.7-41.1) months after the final clinic visit, 31.2% still coughed persistently, while 68.8% reported cough improvement or remission. RCC reported more favorable treatment outcomes (including cough improvement, control, and spontaneous remission) than UCC (P < 0.01). Coughs with long duration before the initial cough clinic visit (P < 0.01), frequent urinary incontinence (P < 0.01), and being sensitive to "talking" (P < 0.01) or "cold air" (P < 0.01) were less likely to be solved.Conclusions: The current treatments only improve cough symptoms in two-thirds of patients. Clinical indicators for treatment failure were those coughing for long duration and being sensitive to "talking" or "cold air."
引用
收藏
页码:795 / 811
页数:17
相关论文
共 50 条
  • [1] Burden of refractory and unexplained chronic cough on patients' lives: a cohort study
    Puente-Maestu, Luis
    Davila, Ignacio
    Quirce, Santiago
    Crespo-Lessmann, Astrid
    Martinez-Moragon, Eva
    Sola, Javier
    Luisa Nieto, Maria
    Javier Gonzalez-Barcala, Francisco
    Cea-Calvo, Luis
    Sanchez-Jareno, Marta
    Rivas-Pardinas, Cristina
    Domingo, Christian
    ERJ OPEN RESEARCH, 2023, 9 (05)
  • [2] Unexplained or Refractory Chronic Cough in Adults
    Irwin, Richard S.
    Madison, J. Mark
    NEW ENGLAND JOURNAL OF MEDICINE, 2025, 392 (12) : 1203 - 1214
  • [3] Prevalence of refractory and unexplained chronic cough in adults treated in cough centre
    Kukielka, Pawel
    Moliszewska, Katarzyna
    Bialek-Gosk, Katarzyna
    Grabczak, El z bieta M.
    Dabrowska, Marta
    ERJ OPEN RESEARCH, 2024, 10 (05)
  • [4] Current opinion in refractory and/or unexplained chronic cough
    Misono, Stephanie
    Novaleski, Carolyn K.
    CURRENT OPINION IN OTOLARYNGOLOGY & HEAD AND NECK SURGERY, 2024, 32 (06) : 403 - 409
  • [5] Refractory and unexplained chronic cough: burden and cost of care
    Smith, Jacky
    Stein, Norman
    Migas, Sylwia
    Bokowski, Sue
    Williams, Claire
    Baker, Patricia
    New, John
    Schelfhout, Jonathan
    Fonseca, Eileen
    Langerman, Haya
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [6] Predictors of treatment response to pregabalin in unexplained or refractory chronic cough
    St-Pierre, Mathieu D.
    RESPIRATORY MEDICINE, 2023, 218
  • [7] Comparison of differences in refractory and unexplained chronic cough patients in Germany: VICHAS study
    Jannowitz, Christina
    Kardos, Peter
    Worth, Heinrich
    Horack, Martin
    Kohler, Ulrich
    Karmann, Barbara
    Gillissen, Adrian
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [8] Impaired cough suppression in chronic refractory cough
    Cho, Peter S. P.
    Fletcher, Hannah, V
    Turner, Richard D.
    Jolley, Caroline J.
    Birring, Surinder S.
    EUROPEAN RESPIRATORY JOURNAL, 2019, 53 (05)
  • [9] Patient-reported experiences with refractory or unexplained chronic cough: a qualitative analysis
    Bali, Vishal
    Schelfhout, Jonathan
    Sher, Mandel R.
    Tripathi Peters, Anju
    Patel, Gayatri B.
    Mayorga, Margaret
    Goss, Diana
    Romano, Carla
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2024, 18
  • [10] Tachyphylaxis and Dependence in Pharmacotherapy for Unexplained Chronic Cough
    Bowen, Andrew J.
    Huang, Tiffany L.
    Nowacki, Amy S.
    Trask, Douglas
    Kaltenbach, James
    Taliercio, Rachel
    Benninger, Michael S.
    Milstein, Claudio F.
    Bryson, Paul C.
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2018, 159 (04) : 705 - 711